Publication | Closed Access

7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages

InflammationAnti-inflammatorySignal TransductionImmune Cell DevelopmentMedicineImmunologyRenal InflammationChronic InflammationImmune RegulationAnti-inflammatory EffectsLps-stimulated Raw264.7 MacrophagesInnate ImmunityImmune FunctionTargeted-inhibiting Tak1PharmacologyInflammatory DiseaseCell SignalingMolecular Signaling